SCHEMBL29566691

SCHEMBL29566691

CCc1c(Cl)nc(NS(=O)(=O)c2cnn(C)c2)nc1Oc1ccc(N2CCNCC2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 4/20 0.38
▸ HTR6 P50406 1/20 0.37
▸ GUSB P08236 1/20 0.36
▸ ACVR1 Q04771 6/20 0.35
▸ RIPK2 O43353 5/20 0.35
▸ NOD2 Q9HC29 5/20 0.35
▸ NMT1 P30419 1/20 0.35
▸ CCR2 P41597 1/20 0.35
▸ PLA2G7 Q13093 1/20 0.34
▸ HTR3E A5X5Y0 1/20 0.33
▸ HTR3B O95264 1/20 0.33
▸ ADRB1 P08588 1/20 0.33
▸ HTR3A P46098 1/20 0.33
▸ HTR3D Q70Z44 1/20 0.33
▸ HTR3C Q8WXA8 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ AXL P30530 1/20 0.33
▸ MERTK Q12866 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309487 1.00 LTA4H (0.38) LTA4HHTR6GUSBACVR1RIPK2
SCHEMBL26811476 0.90 LTA4H (0.41) LTA4HHTR6ACVR1RIPK2NOD2
SCHEMBL26811440 0.88 HTR6 (0.41) LTA4HHTR6GUSBACVR1RIPK2
SCHEMBL29566605 0.88 GUSB (0.37) LTA4HHTR6GUSBACVR1RIPK2
SCHEMBL24309488 0.88 GUSB (0.37) LTA4HHTR6GUSBACVR1RIPK2
SCHEMBL26811436 0.87 SLC2A1 (0.39) LTA4HHTR6GUSBACVR1RIPK2
SCHEMBL29567543 0.86 LCK (0.37) LTA4HHTR6GUSBACVR1RIPK2
SCHEMBL24310035 0.86 LCK (0.37) LTA4HHTR6GUSBACVR1RIPK2
SCHEMBL26811450 0.86 GUSB (0.36) LTA4HHTR6GUSBACVR1RIPK2
SCHEMBL24309496 0.85 NOD2 (0.36) HTR6ACVR1RIPK2NOD2AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback